< Back to companies

Nextbio is a privately owned software company that provides an innovative platform for life science researchers and drug development teams to search, discover, and share knowledge across public and proprietary biological and genomic data. The Nextbio Platform is an ontology-based semantic framework that integrates heterogeneous data types—including gene, tissue, disease, and compound information—from multiple organisms and platforms. It enables researchers to identify prognostic and predictive molecular signatures, accelerate drug discovery, and improve collaboration across therapeutic areas and geographic locations. The platform is delivered as a SaaS solution, supporting rapid deployment and integration of internal data with public datasets.

Share
Shareable draft
Get Involved in Nextbio

Company Info

Founded
2018
Website
nextandbio.com/en/?ckattempt=2

Categories

Life SciencesResearch, Evidence & KnowledgeHealth Data & ITScientific Publishing & Knowledge

Disease Areas

Technologies

Software PlatformLife Sciences SoftwareKnowledge Graphs
Only accessible to MedStartr community members. Join now

What do you think of Nextbio?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Nextbio
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free